• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor Regarding "Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients".

作者信息

Wolf Julia, Smythe Jon, Griffin James

机构信息

National Health Service Blood and Transplant, Filton, United Kingdom; Bristol Haematology and Oncology Centre, Bristol, United Kingdom.

National Health Service Blood and Transplant, Oxford, United Kingdom.

出版信息

Transplant Cell Ther. 2021 Mar;27(3):199-200. doi: 10.1016/j.jtct.2020.11.010. Epub 2020 Dec 14.

DOI:10.1016/j.jtct.2020.11.010
PMID:35348115
Abstract
摘要

相似文献

1
Letter to the Editor Regarding "Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients".致编辑的信：关于“骨髓瘤患者为未来挽救性自体移植或干细胞强化而储存的造血祖细胞的利用及成本影响”
Transplant Cell Ther. 2021 Mar;27(3):199-200. doi: 10.1016/j.jtct.2020.11.010. Epub 2020 Dec 14.
2
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.储存造血祖细胞以备将来挽救性自体移植或骨髓瘤患者干细胞增强治疗的利用和成本影响。
Biol Blood Marrow Transplant. 2020 Nov;26(11):2011-2017. doi: 10.1016/j.bbmt.2020.07.019. Epub 2020 Jul 24.
3
Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.在包括符合mSMART标准的多发性骨髓瘤患者中，用于挽救性自体移植的储存外周血干细胞成本高昂且利用率低。
Bone Marrow Transplant. 2021 Jun;56(6):1458-1461. doi: 10.1038/s41409-021-01223-y. Epub 2021 Jan 29.
4
Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.多发性骨髓瘤自体造血干细胞移植：常见问题解答
Clin J Oncol Nurs. 2013 Dec;17 Suppl:43-7. doi: 10.1188/13.CJON.43-47.
5
High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial.高剂量化疗联合自体造血干细胞移植作为既往自体造血干细胞移植后复发多发性骨髓瘤患者的巩固治疗（NCRI 骨髓瘤 X 复发[强化试验]）：一项随机、开放标签、3 期试验。
Lancet Oncol. 2014 Jul;15(8):874-85. doi: 10.1016/S1470-2045(14)70245-1. Epub 2014 Jun 16.
6
The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.接受初始移植后维持治疗的多发性骨髓瘤患者中挽救性自体干细胞移植的疗效。
Bone Marrow Transplant. 2018 Nov;53(11):1483-1486. doi: 10.1038/s41409-018-0216-3. Epub 2018 May 24.
7
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.基于硼替佐米的再诱导治疗后自体移植后复发骨髓瘤的干细胞采集：英国血液与骨髓移植学会/英国骨髓瘤论坛骨髓瘤X（强化）试验结果
Biol Blood Marrow Transplant. 2016 Jun;22(6):1009-1016. doi: 10.1016/j.bbmt.2016.01.016. Epub 2016 Jan 28.
8
Salvage second transplantation in relapsed multiple myeloma.复发多发性骨髓瘤的挽救性二次移植
Leukemia. 2021 Apr;35(4):1214-1217. doi: 10.1038/s41375-020-1005-8. Epub 2020 Aug 4.
9
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.多发性骨髓瘤挽救性第三自体干细胞移植的结果。
Biol Blood Marrow Transplant. 2018 Jul;24(7):1372-1378. doi: 10.1016/j.bbmt.2018.01.035. Epub 2018 Feb 3.
10
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.多发性骨髓瘤患者首次自体移植失败后的第二次自体或异基因移植。
Cancer. 2006 Mar 1;106(5):1084-9. doi: 10.1002/cncr.21700.

引用本文的文献

1
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?确定在多发性骨髓瘤挽救性移植中有效利用储存自体外周血干细胞的候选者：谁获益最大？
Hematol Rep. 2024 Jul 12;16(3):479-486. doi: 10.3390/hematolrep16030046.
2
Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience.多发性骨髓瘤患者第二次（或以上）自体造血细胞移植中使用冻存自体外周血造血细胞的趋势：单中心经验。
Bone Marrow Transplant. 2023 Oct;58(10):1130-1136. doi: 10.1038/s41409-023-02035-y. Epub 2023 Jul 21.